MS
Md Sadique Islam
About Md Sadique Islam
Data last updated:
Md Sadique Islam is a Director at Unolyn Pharma International Private Limited (since 2022) and Director at Acure Pharma Private Limited (since 2021). The companies operate in Chemicals.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Jan 2022 | 2022 | Active | ||
| Director | 22 Nov 2021 | 2021 | Active |
Board colleagues of Md Sadique Islam
| Name | DIN | Company | Designation |
|---|---|---|---|
| Izaz Ahmed Gazi | 09464557 | Unolyn Pharma International Private Limited | Director |
| Mohammed Najib Ahmed | 03626233 | Unolyn Pharma International Private Limited , Acure Pharma Private Limited | Director |
| Tanvir Anjum Laskar | 09394760 | Unolyn Pharma International Private Limited , Acure Pharma Private Limited | Director |
| Rabiul Hoque Molla | 09393387 | Acure Pharma Private Limited | Director |
| Sabina Yeasmin | 09394761 | Acure Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Md Sadique Islam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Md Sadique Islam
Md Sadique Islam currently holds 2 directorships: Unolyn Pharma International Private Limited (Director, since 19 Jan 2022); Acure Pharma Private Limited (Director, since 22 Nov 2021).
Md Sadique Islam was first appointed on 22 Nov 2021 as Director at Acure Pharma Private Limited. The most recent appointment on record is 19 Jan 2022 at Unolyn Pharma International Private Limited.
The current boards of Md Sadique Islam's companies include Izaz Ahmed Gazi (Unolyn Pharma International Private Limited), Mohammed Najib Ahmed (Unolyn Pharma International Private Limited), Tanvir Anjum Laskar (Unolyn Pharma International Private Limited), Rabiul Hoque Molla (Acure Pharma Private Limited), Sabina Yeasmin (Acure Pharma Private Limited).